Logo do repositório
 
Publicação

Enhancing Alzheimer's Disease Diagnosis and Care by Focusing on Plasma Biomarkers for Identifying Mild Cognitive Impairment

2024-09-24Recensão Acesso aberto
Ver registo simples
dc.contributor.authorCardoso, Remy
dc.contributor.authorTeunissen, Charlotte E.
dc.contributor.authorOliveira, Catarina Resende
dc.contributor.institutionNOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)
dc.contributor.pblIOS Press
dc.date.accessioned2025-03-21T21:21:27Z
dc.date.available2025-03-21T21:21:27Z
dc.date.issued2024-09-24
dc.description10510032120003) in the context of the Dutch National Dementia Strategy. Publisher Copyright: © 2024 - IOS Press. All rights reserved.
dc.description.abstractBiomarkers that accurately identify mild cognitive impairment (MCI) are of greater importance for Alzheimer's disease (AD) management and treatment. On the other hand, blood-based biomarkers are not only more practical but also less invasive than the common cerebrospinal fluid biomarkers. In their report in the Journal of Alzheimer's Disease, Wang and collaborators identified 67 upregulated and 220 downregulated long noncoding RNAs (lncRNAs). They further demonstrated that 4 of these lncRNAs could discriminate MCI from cognitively healthy individuals. Apart from their significance as potential biomarkers for MCI diagnosis, these lncRNAs can offer additional information on the cellular mechanisms of AD pathology.en
dc.description.versionpublishersversion
dc.description.versionpublished
dc.format.extent4
dc.format.extent97666
dc.identifier.doi10.3233/JAD-240724
dc.identifier.issn1387-2877
dc.identifier.otherPURE: 113449604
dc.identifier.otherPURE UUID: cb356b26-65fc-488e-a336-c7cc5839ebe3
dc.identifier.otherScopus: 85205275325
dc.identifier.otherPubMed: 39240643
dc.identifier.otherWOS: 001331308800003
dc.identifier.urihttp://hdl.handle.net/10362/181089
dc.identifier.urlhttps://www.scopus.com/pages/publications/85205275325
dc.language.isoeng
dc.peerreviewedyes
dc.relationFunding Information: Research of CET is supported by the European Commission (Marie Curie International Training Network, grant agreement No 860197 (MIRIADE), Innovative Medicines Initiatives 3TR (Horizon 2020, grant no 831434) EPND (IMI 2 Joint Undertaking (JU), grant No. 101034344) and JPND (bPRIDE), National MS Society (Progressive MS alliance), CANTATE project funded by the Alzheimer Drug Discovery Foundation, Alzheimer Association, Health Holland, the Dutch Research Council (ZonMW), Alzheimer Drug Discovery Foundation, The Selfridges Group Foundation, Alzheimer Netherlands. CT is recipient of ABOARD, which is a public-private partnership receiving funding from ZonMW (
dc.relation73305095007) and Health\u223CHolland, Topsector Life Sciences & Health (PPP-allowance;
dc.relationLSHM20106). CT is recipient of TAP-dementia, a ZonMw funded project (
dc.relation10510032120003) in the context of the Dutch National Dementia Strategy. Funding Information: Research of CET is supported by the European Commission (Marie Curie International Training Network, grant agreement No 860197 (MIRIADE), Innovative Medicines Initiatives 3TR (Horizon 2020, grant no 831434) EPND (IMI 2 Joint Undertaking (JU), grant No. 101034344) and JPND (bPRIDE), National MS Society (Progressive MS alliance), CANTATE project funded by the Alzheimer Drug Discovery Foundation, Alzheimer Association, Health Holland, the Dutch Research Council (ZonMW), Alzheimer Drug Discovery Foundation, The Selfridges Group Foundation, Alzheimer Netherlands. CT is recipient of ABOARD, which is a public-private partnership receiving funding from ZonMW (
dc.relation73305095007) and Health-Holland, Topsector Life Sciences & Health (PPP-allowance;
dc.relationLSHM20106). CT is recipient of TAP-dementia, a ZonMw funded project (
dc.subjectAlzheimer's disease
dc.subjectbiomarkers
dc.subjectlncRNA
dc.subjectmild cognitive impairment
dc.subjectplasma
dc.subjectGeneral Neuroscience
dc.subjectClinical Psychology
dc.subjectGeriatrics and Gerontology
dc.subjectPsychiatry and Mental health
dc.subjectSDG 3 - Good Health and Well-being
dc.titleEnhancing Alzheimer's Disease Diagnosis and Care by Focusing on Plasma Biomarkers for Identifying Mild Cognitive Impairmenten
dc.typereview
degois.publication.firstPage731
degois.publication.issue3
degois.publication.lastPage734
degois.publication.titleJournal of Alzheimer's Disease
degois.publication.volume101
dspace.entity.typePublication
rcaap.rightsopenAccess

Ficheiros

Principais
A mostrar 1 - 1 de 1
Miniatura
Nome:
cardoso-et-al-2024-enhancing-alzheimer-s-disease-diagnosis-and-care-by-focusing-on-plasma-biomarkers-for-identifying.pdf
Tamanho:
95.38 KB
Formato:
Adobe Portable Document Format
Ver/Abrir

Coleções

NMS - Artigos em revista internacional com arbitragem científica